期刊文献+

1,25-二羟维生素D3对高糖诱导肾小管上皮细胞解耦联蛋白2表达及氧化应激的影响 被引量:8

Effects of 1,25-dihydroxyvitamin D3 on high glucose-induced expression of uncoupling protein 2 and oxidative stress in human renal tubular epithelial cells
原文传递
导出
摘要 体外培养的HK-2细胞分为正常对照组(NG组,5.5mmol/LD-葡萄糖)、高糖处理组(HG组,30mmol/LD-葡萄糖)、高渗对照组(MG组,5.5mmol/LD-葡萄糖+24.5mmol/LD-甘露醇)、高糖培养液中又加入不同浓度的1,25-二羟维生素D3[1,25-(OH)2D3]组(V1~V3组)、N-乙酰半胱氨酸药效对照组(NAC组,30mmol/LD-葡萄糖+1.0mmol/LN-乙酰半胱氨酸)和无水乙醇溶剂对照组(SG组,30mmol/LD-葡萄糖+6.86×10-2mol/L乙醇)。检测细胞活性氧簇荧光强度、线粒体膜电位、解耦联蛋白2(UCP2)mRNA、蛋白表达、总超氧化物歧化酶(SOD)活力和丙二醛水平。结果HG组细胞的线粒体膜电位明显低于NG组(P〈0.01),1,25-(OH)2D3处理后细胞的线粒体膜电位与HG组比较显著下降(均P〈0.01);HG组总SOD活力显著低于NG组(P〈0.01),丙二醛含量明显高于NG组(P〈0.01),而1,25-(OH)2D3处理后细胞总SOD活力较HG组显著增高(P〈0.05),丙二醛水平显著低于HG组(P〈0.01);HG组UCP2mRNA与蛋白表达显著高于NG组(P〈0.05),而1,25-(OH)2D3处理后细胞UCP2的表达与HG组比较显著降低(P〈0.01)。结果表明高糖可诱导体外培养的HK-2细胞氧化应激损伤;1,25-(OH)2D3可能通过降低线粒体膜电位、活性氧簇生成及调节胞内UCP2表达抑制高糖诱导的氧化应激反应。 The HK-2 cells with different culture media were divided into normal glucose group(NG group, 5.5 mmol/L D-glucose); high glucose group(HG group, 30 mmol/L D-glucose); mannitol group(MG group, 5.5 mmol/L D-glucose+24.5 mmol/L mannitol); 1,25-dihydroxyvitamin D3[1,25-(OH)2D3] groups(V1-V3 group)which were exposed to medium containing 30 mmol/L D-glucose and different concentrations of 1,25-(OH)2D3; Nethyl-cysteim control group(NAC group, 30 mmol/L D-glucose +1.0 mmol/L N-Nethyl-cysteim); and ethanol control group(SG group, 30 mmol/L D-glucose+6.86×10-2 mol/L ethanol). The level of intracellular reactive oxygen species, mitochondrial membrane potential, activity of total-superoxide dismutase(T-SOD), level of malondialdehyde, expression of UCP2 mRNA and protein in HK-2 cells were detected. Compared with NG group, the mitochondrial membrane potential significantly decreased in HG group(P〈0.01), and the mitochondrial membrane potential in V group was lower than that in HG group(P〈0.01). The activity of T-SOD in HG group was significantly lower than that in NG group(P〈0.01), while its level of malondialdehyde was significantly higher than that in NG group(P〈0.01). Compared with HG group, the activity of T-SOD in V groups was significantly increased(P〈0.05)and the level of malondialdehyde in these groups significantly decreased(P〈0.01). The mRNA expression of UCP2 in HG group was increased significantly in comparison with NG group(P〈0.05)and the expression in V groups was significantly decreased in comparison with HG group( P〈0.01). The results suggest that 1,25-(OH)2D3 could reduce the mitochondrial membrane potential, the production of reactive oxygen species, and regulate the expression of UCP2 in order to suppress the oxidative stress induced by high glucose.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第10期849-852,共4页 Chinese Journal of Endocrinology and Metabolism
关键词 糖尿病肾病 1 25-二羟维生素D3 HK-2细胞 解耦联蛋白2 氧化应激 Diabetic nephropathy 1,25-dihydroxyvitamin D3 Human renal tubular epithelial cells Uncoupling protein 2 Oxidative stress
  • 相关文献

参考文献20

  • 1Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev, 2005,26:662-687.
  • 2Tian J, Liu Y, Williams LA, et al. Potential role of active vitamin D in retarding the progression of chronic kidney disease. Nephrol Dial Transplant, 2007,22:321-328.
  • 3Sun X, Zemel MB. Role of uncoupling protein 2 expression and 1 alpha, 25-dihydroxyvitamin D3 in modulating adipocyte apoptosis. FASEB J, 2004,18 : 1430-1432.
  • 4Wong KE, Szeto FL, Zhang W, et al. Involvement of the Vitamin D Receptor in Energy Metabolism : Regulation of uncoupling proteins. Am J Physiol Endocrinol Metab, 2009,59 : E820-E828.
  • 5Li L, Prabhakaran K, Zhang X, et al. lcl, 25-dihydroxyvitamin D3 attenuates cyanide induced neurotoxicity by inhibiting uncoupling protein-2 up-regulation. Neurosci Res, 2008,86 : 1397-1408.
  • 6Friederich M, Nordquist L, Olerud J, et al. Identification and distribution of uncoupling protein isoforms in the normal and diabetic rat kidney. Adv Exp Med Bio, 2009,645:205-212.
  • 7许益笑,王德选,李素娟,林艳红,方周溪,汪洋,金可可.血糖波动对糖尿病大鼠肾脏氧化应激与凋亡的影响[J].中华内分泌代谢杂志,2012,28(4):325-329. 被引量:17
  • 8Brownlee M. Biochemistry and molecular cell biology of diabeticcomplications. Nature, 2001,414 : 813-820.
  • 9刘会苗,秦贵军,余勤,董义光,任高飞.2型糖尿病肾病患者血清25-(OH)维生素D3的变化及意义[J].中华内分泌代谢杂志,2011,27(12):1002-1003. 被引量:24
  • 10Tian J, Liu Y, Williams LA, et al. Potential role of active vitamin D in retarding the progression of chronic kidney disease. Nephrol Dial Transplant, 2007,22: 321-328.

二级参考文献34

  • 1李慧敏,缪珩,鲁一兵,成金罗,耿厚法,蒋秀琴.中国汉族人群维生素D受体基因多态性与糖尿病肾病的易感性[J].中国临床康复,2005,9(47):1-4. 被引量:15
  • 2Nagpal S,Na S,Rathnachalam R.Noncalcemic actions of vitamin D receptor ligands.Endccr Rev,2005,26:662-687.
  • 3Kuhlmann A,Haas CS,Gross ML,et al.1,25-Dihydroxy-vitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.Am J Physiol Renal Physiol,2004,286:526-533.
  • 4Deb DK,Chen Y,Zhang Z,et al.1,25-Dihydroxy-vitamin D3 suppresses high glucose-induced angioten-sinogen expression in kidney cells by blocking the NF-κB pathway.Am J Physiol Renal Physiol,2009,296:1212-1218.
  • 5Zhang Z,Zhang Y,Ning J,et al.Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy:blockade of compensatory reninin crease.Proc Nat 1 Acad Sci USA,2008,105:15896-15901.
  • 6Panichi V,Migliori M,Taccola D,et al.Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.Kindney Int,2001,60:87-95.
  • 7Diaz VA,Mainous AG,Carek PI,et al,The association of vitamin D deficiency and insufficiency with diabetic nephropathy implications for health disparities.Jam Board Fam Med,2009,22:521-527.
  • 8Zachary T,Bloomgarden MD.Blood pressure and diabetic nephropathy.Diabetes Care,2010,33 (3):e30-e35.
  • 9Forman JP,Giovannucci E,Holmes MD,et al.Plasma 25-hydroxy-vitamin D levels and risk of incident hypertension.Hypertension,2007,49:1063-1069.
  • 10American Diabetes Association. Standards of medical care in diabetes- 2009. Diabetes Care, 2009,32 (Suppl 1 ) :$13-$61.

共引文献43

同被引文献60

  • 1史良,龙圆圆,莎梦琪,罗茜,田润梅,黄佩,陈艳.BAX基因缺失加速BCR-ABL诱导的小鼠B-ALL疾病进程[J].中国实验血液学杂志,2020,28(1):29-33. 被引量:2
  • 2谷万章,王玉国,周丽霞.浅谈视网膜新生血管[J].中国实用眼科杂志,2004,22(8):589-590. 被引量:13
  • 3Jeng L, Yamshchikov AV, Judd SE, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med, 2009,7:25.
  • 4Johannes PTM, Van Leeuwen, Huibert AP. Cancer and differenti- ation. In: Feldman D, Pike JW, Glorieux FH, eds. VITAMIN D. 2nd ed. Amsterdam: ELSEVIER Academic Press, 2005 : 1571-1598.
  • 5Wild S, Roglic G, Green A, Sicree R, King H. GlobalPrevalence of Diabetes: Estimates for the year 2000 andprojections for 2030. Diabetes Care, 2004,27: 1047-53.
  • 6Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, KowalskiJW,Bek T, et al. Global prevalence and major risk factors ofdiabetic retinopathy. Diabetes Care,2012, 35: 556-64.
  • 7Plum LA, DeLuca HF. Vitamin D, disease and therapeuticopportunities. Nature Reviews Drug Discovery. 2010, 9:941-55.
  • 8Chagas CEA, Borges MC, Martini LA, et al. Focus on vitaminD, inflammation and type 2 diabetes. Nutrients,2012, 4:52-67.
  • 9Guillot X,Semerano L, Saidenberg-Kermanac * h N, et al.Vitamin D and inflammation. Joint Bone Spine. 2010; 77:552-7.
  • 10Aksoy H,Ak(Sy F,Kurtul N, Baykal 0, Avci B. Serum 1,25dihydroxy vitamin D (1,25 (OH) 2 D 3),25 hydroxy vitaminD (25 (OH) D) and parathormone levels in diabeticretinopathy. Clinical Biochemistry, 2000,33: 47-51.

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部